Management of Nontuberculous Mycobacterial (NTM) Lung Disease

NTM lung disease is a pulmonary infection that can cause chronic, debilitating disease. This brochure contains information on management of NTM lung disease, including the latest recommendations from the 2020 NTM Lung Disease Guidelines on treatment and monitoring.


This website includes information on NTM lung disease susceptibility, screening, diagnosis, and treatment. A series of downloadable resources are also available to share with patients who may be at risk for developing NTM lung disease or those who have already been diagnosed. 



NEW 2020 NTM Lung Disease Treatment Guidelines

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline

The NTM Lung Disease Treatment Guidelines were developed by a panel of experts carefully selected by leading international respiratory medicine and infectious disease societies, including the American Thoracic Society (ATS), European Respiratory Society (ERS), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Infectious Diseases Society of America (IDSA). The Guidelines are intended for use by healthcare professionals who care for patients with NTM lung disease, including those that specialize in infectious and pulmonary diseases.



Brought to you by Insmed Incorporated